Cryptogenic stroke prevention through venous thromboembolism prevention: Potential and truth in the advent of non-vitamin K antagonist oral anticoagulants

類似資料

• Venous Thromboembolism Prevention in Nephrotic Syndrome: The Role of Aspirin, Vitamin K Antagonists, and Direct Oral Anticoagulants
  著者:: Zohreh Gholizadeh Ghozloujeh, 等
  出版事項: (2025-05-01)
• New Options in Anticoagulation for the Prevention Of Venous Thromboembolism and Stroke
  著者:: Clayville, Lisa R., 等
  出版事項: (2011)
• Effective management of venous thromboembolism in the community: non-vitamin K antagonist oral anticoagulants
  著者:: Patel, Raj
  出版事項: (2016)
• Which patients with venous thromboembolism should receive non-vitamin K antagonist oral anticoagulants? The majority
  著者:: Riva, Nicoletta, 等
  出版事項: (2015)
• Efficacy and safety of non-vitamin K antagonist oral anticoagulants for venous thromboembolism: a meta-analysis
  著者:: Zhuang, Yan, 等
  出版事項: (2021)